Reduced-dose cladribine (2-CdA) plus mitoxantrone is effective in the treatment of mantle-cell and low-grade non-Hodgkin's lymphoma
Rummel, M.J, Chow, K.U, Karakas, T, Jäger, E, Mezger, J, von Grünhagen, U, Schalk, K.-P, Burkhard, O, Hansmann, M.-L, Ritzel, H, Bergmann, L, Hoelzer, D, Mitrou, P.S
Published in European journal of cancer (1990) (01.09.2002)
Published in European journal of cancer (1990) (01.09.2002)
Get full text
Journal Article
PS1253 MAGNIFY: PHASE IIIB INTERIM ANALYSIS OF INDUCTION #R2 FOLLOWED BY MAINTENANCE IN PATIENTS WITH RELAPSED/REFRACTORY INDOLENT NON‐HODGKIN LYMPHOMA
Rummel, M.J., Andorsky, D.J., Coleman, M., Yacoub, A., Melear, J.M., Fanning, S.R., Kolibaba, K.S., Lansigan, F., Reynolds, C., Foon, K., Li, J., Llorente, M., Sharman, J.
Published in HemaSphere (01.06.2019)
Published in HemaSphere (01.06.2019)
Get full text
Journal Article
Remission of a B cell CLL-associated membranoproliferative glomerulonephritis Type I with rituximab and bendamustine
Bartel, C, Obermüller, N, Rummel, M J, Geiger, H, Hauser, I A
Published in Clinical nephrology (01.04.2008)
Published in Clinical nephrology (01.04.2008)
Get more information
Journal Article
Treatment of mantle-cell lymphomas with intermittent two-hour infusion of cladribine as first-line therapy or in first relapse
Rummel, M. J., Chow, K. U., Jäger, E., Hossfeld, D. K., Bergmann, L., Peter, H.-D., Hansmann, M.-L., Meyer, A., Hoelzer, D., Mitrou, P. S.
Published in Annals of oncology (01.01.1999)
Published in Annals of oncology (01.01.1999)
Get full text
Journal Article
Treatment of aggressive, or progressing indolent peripheral T- and NK-cell neoplasias by combination of fludarabine, cyclophosphamide and doxorubicine
Weidmann, E, Boehrer, S, Chow, K U, Engels, K, Harder, L, Hinz, T, Janssen, O, Kriener, S, Rummel, M J, Siebert, R, Kabelitz, D, Hansmann, M L, Hoelzer, D, Mitrou, P S
Published in Onkologie (01.04.2001)
Published in Onkologie (01.04.2001)
Get more information
Journal Article